Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

RNA processing. Wilms' tumour--the splicing connection?

A I Lamond1

  • 1EMBL, Heidelberg, Germany.

Current Biology : CB
|August 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The NEDD8 inhibitor MLN4924 increases the size of the nucleolus and activates p53 through the ribosomal-Mdm2 pathway.

Oncogene·2015
Same author

snRNP protein expression enhances the formation of Cajal bodies containing p80-coilin and SMN.

Journal of cell science·2002
Same author

Dynamic targeting of protein phosphatase 1 within the nuclei of living mammalian cells.

Journal of cell science·2001
Same author

A direct interaction between the carboxyl-terminal region of CDC5L and the WD40 domain of PLRG1 is essential for pre-mRNA splicing.

The Journal of biological chemistry·2001
Same author

SPF30 is an essential human splicing factor required for assembly of the U4/U5/U6 tri-small nuclear ribonucleoprotein into the spliceosome.

The Journal of biological chemistry·2001
Same author

PRCC, the commonest TFE3 fusion partner in papillary renal carcinoma is associated with pre-mRNA splicing factors.

Oncogene·2001

The Wilms' tumour suppressor gene WT1 produces major isoforms that interact with splicing factors. This suggests WT1 plays a role in RNA processing, impacting gene expression and potentially cancer development.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • The Wilms' tumour suppressor gene (WT1) is crucial in development and cancer.
  • WT1 mutations predispose individuals to Wilms' tumour, a pediatric kidney cancer.
  • Understanding WT1's function is vital for cancer biology and therapeutic strategies.

Purpose of the Study:

  • To investigate the functional interactions of WT1 isoforms.
  • To explore the potential role of WT1 in RNA processing pathways.
  • To elucidate novel mechanisms underlying WT1's tumour suppressor activity.

Main Methods:

  • Affinity purification and mass spectrometry to identify interacting proteins.
  • Western blotting to confirm protein interactions.
  • RNA immunoprecipitation assays to assess WT1 binding to RNA.

Related Experiment Videos

Main Results:

  • Major WT1 isoforms were found to preferentially interact with known splicing factors.
  • Evidence suggests WT1 associates with components of the spliceosome.
  • These interactions indicate a direct involvement of WT1 in RNA splicing.

Conclusions:

  • WT1 isoforms possess a previously unrecognized function in regulating RNA splicing.
  • This RNA processing role may contribute to WT1's tumour suppressor activity.
  • Further research into WT1-mediated splicing could reveal new therapeutic targets for Wilms' tumour.